COMP <GO>
ESAB vs BMI // PIOTROSKI F-SCORE QUALITY
ESAB Corporation (NYSE) VS. Badger Meter Inc. (NYSE) • 15-METRIC TALLY: ESAB 4
— BMI 10
▲ PIOTROSKI F-SCORE QUALITY LEADER: BMI
LAST: $76.30 (+9.38%) • MKT CAP: $4.34B
piotroski-score
7/9
LAST: $157.69 (+6.27%) • MKT CAP: $4.24B
piotroski-score
9/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ESAB VS. BMI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ESAB | BMI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.90% | 41.70% | -4.80 | BMI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.10% | 18.30% | -8.20 | BMI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.5x | 22.3x | -9.80 | ESAB | /valuation <GO> |
| Free Cash Flow Yield | 4.63% | 3.97% | +0.66 | ESAB | /fcf-yield <GO> |
| Operating Margin | 14.50% | 20.00% | -5.50 | BMI | /operating-margins <GO> |
| Net Profit Margin | 8.00% | 15.50% | -7.50 | BMI | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 10.90% | -7.20 | BMI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.48% | 1.02% | -0.54 | BMI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.35 | 8.42 | -6.07 | BMI | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 9/9 | -2.00 | BMI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.5 | 61.3 | -10.80 | BMI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 1.14 | -0.25 | BMI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.9x | 28.1x | -9.20 | ESAB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.34B | $4.24B | $98.6M | ESAB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ESAB REV | BMI REV | ESAB GROSS % | BMI GROSS % | ESAB FCF | BMI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.84B | $916.7M | 36.9% | 41.7% | $213.3M | $169.7M |
| FY 2024 | $2.74B | $826.6M | 37.9% | 39.8% | $303.6M | $142.2M |
| FY 2023 | $2.77B | $703.6M | — | — | $205.6M | $78.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ESAB // BETA 0.89
BMI // BETA 1.14